Dicerna Pharmaceuticals, Inc. Debt to Equity Ratio 2013-2021 | DRNA
Current and historical debt to equity ratio values for Dicerna Pharmaceuticals, Inc. (DRNA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Dicerna Pharmaceuticals, Inc. debt/equity for the three months ending September 30, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-09-30 | $0.66B | $0.11B | 6.17 |
| 2021-06-30 | $0.73B | $0.11B | 6.55 |
| 2021-03-31 | $0.56B | $0.13B | 4.41 |
| 2020-12-31 | $0.57B | $0.14B | 4.14 |
| 2020-09-30 | $0.53B | $0.15B | 3.44 |
| 2020-06-30 | $0.57B | $0.16B | 3.52 |
| 2020-03-31 | $0.60B | $0.18B | 3.38 |
| 2019-12-31 | $0.45B | $0.15B | 2.93 |
| 2019-09-30 | $0.20B | $0.13B | 1.50 |
| 2019-06-30 | $0.20B | $0.16B | 1.26 |
| 2019-03-31 | $0.20B | $0.18B | 1.14 |
| 2018-12-31 | $0.21B | $0.20B | 1.04 |
| 2018-09-30 | $0.03B | $0.16B | 0.19 |
| 2018-06-30 | $0.03B | $0.07B | 0.39 |
| 2018-03-31 | $0.02B | $0.09B | 0.18 |
| 2017-12-31 | $0.02B | $0.10B | 0.20 |
| 2017-09-30 | $0.09B | $-0.00B | -22.89 |
| 2017-06-30 | $0.08B | $0.01B | 6.14 |
| 2017-03-31 | $0.01B | $0.03B | 0.36 |
| 2016-12-31 | $0.01B | $0.04B | 0.24 |
| 2016-09-30 | $0.01B | $0.05B | 0.19 |
| 2016-06-30 | $0.01B | $0.07B | 0.14 |
| 2016-03-31 | $0.01B | $0.08B | 0.09 |
| 2015-12-31 | $0.01B | $0.09B | 0.10 |
| 2015-09-30 | $0.01B | $0.10B | 0.09 |
| 2015-06-30 | $0.01B | $0.12B | 0.08 |
| 2015-03-31 | $0.01B | $0.09B | 0.07 |
| 2014-12-31 | $0.01B | $0.10B | 0.05 |
| 2014-09-30 | $0.01B | $0.11B | 0.05 |
| 2014-06-30 | $0.00B | $0.12B | 0.03 |
| 2014-03-31 | $0.01B | $0.13B | 0.05 |
| 2013-12-31 | $0.01B | $0.04B | 0.21 |
| 2013-09-30 | $0.01B | $0.05B | 0.18 |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
| 2012-09-30 | $0.00B | 0.00 | |
